This is a 2-arm, randomized, open-label, multicenter, global, Phase 3 trial to evaluate the efficacy, safety, and tolerability of tovorafenib monotherapy versus standard of care (SoC) chemotherapy in patients with pediatric low-grade glioma (LGG)…
- Investigator
- Matthew Cascio
- Status
- Accepting Candidates
- Ages
- N/A - 25 Years
- Sexes
- All